Using a combination of very sensitive assays for detecting BRAF mutations, including laser-capture microdissection, we found substantial evidence for the presence of intra-tumor heterogeneity in primary melanomas and inter-tumor heterogeneity between multiple metastatic tumors from individual patients. The gene discussed is BRAF; the disease is neoplasm.